Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


01.04.2019

1 Am J Med
2 Am J Nephrol
1 BMC Pediatr
5 BMJ
3 Diabet Med
1 Diabetes
2 Diabetes Care
1 Diabetes Educ
5 Diabetes Obes Metab
2 Diabetologia
1 J Am Soc Nephrol
1 J Biol Chem
3 J Clin Endocrinol Metab
1 J Diabetes Complications
1 J Pediatr
1 JAMA
2 Lancet Diabetes Endocrinol
1 N Engl J Med
1 Ophthalmology
3 Pediatr Diabetes
8 PLoS One
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Med

  1. FERRARO RA, Nass CM, Dudum R, Blumenthal RS, et al
    What Clinicians Need to Know About the Cardiovascular Effects of the Most Recent Classes of Drugs Used for Type 2 Diabetes.
    Am J Med. 2019 Mar 20. pii: S0002-9343(19)30250.
    PubMed     Text format     Abstract available


    Am J Nephrol

  2. WOODS TC, Satou R, Miyata K, Katsurada A, et al
    Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus.
    Am J Nephrol. 2019;49:331-342.
    PubMed     Text format     Abstract available

  3. BURNS KD, Cherney D
    Renal Angiotensinogen and Sodium-Glucose Cotransporter-2 Inhibition: Insights from Experimental Diabetic Kidney Disease.
    Am J Nephrol. 2019;49:328-330.
    PubMed     Text format    


    BMC Pediatr

  4. FATANI TH
    EIF2AK3 novel mutation in a child with early-onset diabetes mellitus, a case report.
    BMC Pediatr. 2019;19:85.
    PubMed     Text format     Abstract available


    BMJ

  5. SHAN Z, Bhupathiraju SN
    Authors' reply to Skovenborg and Manfredini and colleagues.
    BMJ. 2019;364:l179.
    PubMed     Text format    

  6. BLACK S
    Flash glucose monitoring devices: CCG criteria are incoherent.
    BMJ. 2018;363:k5203.
    PubMed     Text format    

  7. CHOO VL, Viguiliouk E, Blanco Mejia S, Cozma AI, et al
    Food sources of fructose-containing sugars and glycaemic control: systematic review and meta-analysis of controlled intervention studies.
    BMJ. 2018;363:k4644.
    PubMed     Text format     Abstract available

  8. MILLETT ERC, Peters SAE, Woodward M
    Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants.
    BMJ. 2018;363:k4247.
    PubMed     Text format     Abstract available

  9. KHANDWALA YS, Baker VL, Shaw GM, Stevenson DK, et al
    Association of paternal age with perinatal outcomes between 2007 and 2016 in the United States: population based cohort study.
    BMJ. 2018;363:k4372.
    PubMed     Text format     Abstract available


    Diabet Med

  10. PERAZZOLO M, Reeves ND, Bowling FL, Boulton AJM, et al
    Altered accelerator pedal control in a driving simulator in people with diabetic peripheral neuropathy.
    Diabet Med. 2019 Mar 29. doi: 10.1111/dme.13957.
    PubMed     Text format     Abstract available

  11. SHARIF S, Visseren FLJ, Spiering W, de Jong PA, et al
    Arterial stiffness as a risk factor for cardiovascular events and all-cause mortality in people with Type 2 diabetes.
    Diabet Med. 2019 Mar 28. doi: 10.1111/dme.13954.
    PubMed     Text format     Abstract available

  12. HILL NE, Roscoe D, Stacey MJ, Chew S, et al
    Cheiroarthropathy and tendinopathy in diabetes.
    Diabet Med. 2019 Mar 28. doi: 10.1111/dme.13955.
    PubMed     Text format     Abstract available


    Diabetes

  13. COURTY E, Besseiche A, Do TTH, Liboz A, et al
    Adaptive beta-Cell Neogenesis in the Adult Mouse in Response to Glucocorticoid-Induced Insulin Resistance.
    Diabetes. 2019;68:95-108.
    PubMed     Text format     Abstract available


    Diabetes Care

  14. KYI M, Colman PG, Wraight PR, Reid J, et al
    Early Intervention for Diabetes in Medical and Surgical Inpatients Decreases Hyperglycemia and Hospital-Acquired Infections: A Cluster Randomized Trial.
    Diabetes Care. 2019 Mar 28. pii: dc18-2342. doi: 10.2337/dc18-2342.
    PubMed     Text format     Abstract available

  15. NORONHA JC, Nishi SK, Braunstein CR, Khan TA, et al
    The Effect of Liquid Meal Replacements on Cardiometabolic Risk Factors in Overweight/Obese Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Diabetes Care. 2019 Mar 28. pii: dc18-2270. doi: 10.2337/dc18-2270.
    PubMed     Text format     Abstract available


    Diabetes Educ

  16. KAUSHAL T, Montgomery KA, Simon R, Lord K, et al
    MyDiaText: Feasibililty and Functionality of a Text Messaging System for Youth With Type 1 Diabetes.
    Diabetes Educ. 2019 Mar 22:145721719837895. doi: 10.1177/0145721719837895.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  17. KOSTEV K
    Longitudinal Changes in HbA1c following Therapy Intensification after Inadequate Response to Two Oral Antidiabetic Agents in Patients with Type 2 Diabetes in Germany.
    Diabetes Obes Metab. 2019 Mar 25. doi: 10.1111/dom.13707.
    PubMed     Text format     Abstract available

  18. KLOECKER DE, Zaccardi F, Baldry E, Davies MJ, et al
    Efficacy of Low- and Very-Low-Energy Diets in people with Type 2 Diabetes Mellitus: A systematic review and meta-analysis of interventional studies.
    Diabetes Obes Metab. 2019 Mar 29. doi: 10.1111/dom.13727.
    PubMed     Text format     Abstract available

  19. PETERS A, Piletic M, Ejstrud J, Salvesen-Sykes K, et al
    Baseline nocturnal glucose change: a predictor of the treatment effect of bolus intensification in insulin-treated type 2 diabetes.
    Diabetes Obes Metab. 2019 Mar 29. doi: 10.1111/dom.13729.
    PubMed     Text format     Abstract available

  20. POLLOCK RF, Heller S, Pieber TR, Woo V, et al
    Short-term cost-utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events - a Canadian setting (DEVOTE 9).
    Diabetes Obes Metab. 2019 Mar 29. doi: 10.1111/dom.13730.
    PubMed     Text format     Abstract available

  21. SCHMIDT S, Christensen MB, Serifovski N, Damm-Frydenberg C, et al
    Low versus High Carbohydrate Diet in Type 1 Diabetes: A 12-week randomized open-label crossover study.
    Diabetes Obes Metab. 2019 Mar 29. doi: 10.1111/dom.13725.
    PubMed     Text format     Abstract available


    Diabetologia

  22. HAN T, Zhang S, Duan W, Ren X, et al
    Eighteen-year alcohol consumption trajectories and their association with risk of type 2 diabetes and its related factors: the China Health and Nutrition Survey.
    Diabetologia. 2019 Mar 28. pii: 10.1007/s00125-019-4851.
    PubMed     Text format     Abstract available

  23. KRISTENSEN K, Ogge LE, Sengpiel V, Kjolhede K, et al
    Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies.
    Diabetologia. 2019 Mar 23. pii: 10.1007/s00125-019-4850.
    PubMed     Text format     Abstract available


    J Am Soc Nephrol

  24. ISHIZAWA K, Wang Q, Li J, Xu N, et al
    Inhibition of Sodium Glucose Cotransporter 2 Attenuates the Dysregulation of Kelch-Like 3 and NaCl Cotransporter in Obese Diabetic Mice.
    J Am Soc Nephrol. 2019 Mar 26. pii: ASN.2018070703. doi: 10.1681/ASN.2018070703.
    PubMed     Text format     Abstract available


    J Biol Chem

  25. VAN KRIEKEN R, Mehta N, Wang T, Zheng M, et al
    Cell surface expression of 78 kDa glucose regulated protein (GRP78) mediates diabetic nephropathy.
    J Biol Chem. 2019 Mar 26. pii: RA118.006939. doi: 10.1074/jbc.RA118.006939.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  26. LEROITH D, Biessels GJ, Braithwaite SS, Casanueva FF, et al
    Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2019;104:1520-1574.
    PubMed     Text format     Abstract available

  27. BERBERICH AJ, Huot C, Cao H, McIntyre AD, et al
    Copy Number Variation in GCK in patients with Maturity-Onset Diabetes of the Young.
    J Clin Endocrinol Metab. 2019 Mar 26. pii: 5419225. doi: 10.1210/jc.2018-02574.
    PubMed     Text format     Abstract available

  28. GARCIA-ULLOA AC, Landa-Anell V, Melgarejo-Hernandez M, Villegas-Narvaez A, et al
    Assessment of a multidiscliplinary intervention in patients with BMI >/=35Kg/m2 and recently diagnosed type 2 diabetes.
    J Clin Endocrinol Metab. 2019 Mar 26. pii: 5419223. doi: 10.1210/jc.2018-01148.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  29. FERDINAND AO, Akinlotan MA, Callaghan T, Towne SD Jr, et al
    Diabetes-related hospital mortality in the U.S.: A pooled cross-sectional study of the National Inpatient Sample.
    J Diabetes Complications. 2019 Feb 23. pii: S1056-8727(18)31259.
    PubMed     Text format     Abstract available


    J Pediatr

  30. COOPER HC, Maahs DM
    50 Years Ago in The Journal of Pediatrics: Cortisol Secretion in Acidotic and Nonacidotic Juvenile Diabetes Mellitus.
    J Pediatr. 2019;207:175.
    PubMed     Text format    


    JAMA

  31. ROSENSTOCK J, Allison D, Birkenfeld AL, Blicher TM, et al
    Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial.
    JAMA. 2019 Mar 23. pii: 2729339. doi: 10.1001/jama.2019.2942.
    PubMed     Text format     Abstract available


    Lancet Diabetes Endocrinol


  32. Correction to Lancet Diabetes Endocrinol 2019; 7:288-99.
    Lancet Diabetes Endocrinol. 2019 Mar 20. pii: S2213-8587(19)30110.
    PubMed     Text format    


  33. Correction to Lancet Diabetes Endocrinol 2018; 6: 114-21.
    Lancet Diabetes Endocrinol. 2019;7:e4.
    PubMed     Text format    


    N Engl J Med

  34. FERENCE BA, Ray KK, Catapano AL, Ference TB, et al
    Mendelian Randomization Study of ACLY and Cardiovascular Disease.
    N Engl J Med. 2019;380:1033-1042.
    PubMed     Text format     Abstract available


    Ophthalmology

  35. SAHNI J, Patel SS, Dugel PU, Khanani AM, et al
    Simultaneous Inhibition of Angiopoietin-2 and VEGF-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial.
    Ophthalmology. 2019 Mar 21. pii: S0161-6420(18)33358.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  36. KIM G, Divers J, Fino NF, Dabelea D, et al
    Trends in Prevalence of Cardiovascular Risk Factors from 2002-2012 among Youth Early in the Course of Type 1 and Type 2 Diabetes. The SEARCH for Diabetes in Youth Study.
    Pediatr Diabetes. 2019 Mar 23. doi: 10.1111/pedi.12846.
    PubMed     Text format     Abstract available

  37. MONKEMOLLER K, Muller-Godeffroy E, Lilienthal E, Heidtmann B, et al
    The association between socio-economic status and diabetes care and outcome in children with diabetes type 1 in Germany: the DIAS study (diabetes and social disparities).
    Pediatr Diabetes. 2019 Mar 25. doi: 10.1111/pedi.12847.
    PubMed     Text format     Abstract available

  38. STANEK KR, Youngkin EM, Pyle LL, Raymond JK, et al
    Prevalence, Characteristics and Diabetes Management in Children with Comorbid Autism Spectrum Disorder and Type 1 Diabetes.
    Pediatr Diabetes. 2019 Mar 26. doi: 10.1111/pedi.12848.
    PubMed     Text format     Abstract available


    PLoS One

  39. BHAGWANDIN C, Ashbeck EL, Whalen M, Bandola-Simon J, et al
    The E3 ubiquitin ligase MARCH1 regulates glucose-tolerance and lipid storage in a sex-specific manner.
    PLoS One. 2018;13:e0204898.
    PubMed     Text format     Abstract available

  40. HODEL NC, Hamad A, Praehauser C, Mwangoka G, et al
    The epidemiology of chronic kidney disease and the association with non-communicable and communicable disorders in a population of sub-Saharan Africa.
    PLoS One. 2018;13:e0205326.
    PubMed     Text format     Abstract available

  41. CAPERON L, Arjyal A, K C P, Kuikel J, et al
    Developing a socio-ecological model of dietary behaviour for people living with diabetes or high blood glucose levels in urban Nepal: A qualitative investigation.
    PLoS One. 2019;14:e0214142.
    PubMed     Text format     Abstract available

  42. SCANTLEBERY AML, Uil M, Butter LM, Poelman R, et al
    NLRX1 does not play a role in diabetes nor the development of diabetic nephropathy induced by multiple low doses of streptozotocin.
    PLoS One. 2019;14:e0214437.
    PubMed     Text format     Abstract available

  43. VAZQUEZ-MATEO C, Collins J, Goldberg SJ, Lawson M, et al
    Combining anti-IL-7Ralpha antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.
    PLoS One. 2019;14:e0214379.
    PubMed     Text format     Abstract available

  44. RAVNSBORG T, Svaneklink S, Andersen LLT, Larsen MR, et al
    First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus.
    PLoS One. 2019;14:e0214457.
    PubMed     Text format     Abstract available

  45. ALEXOPOULOS AS, Jackson GL, Edelman D, Smith VA, et al
    Clinical factors associated with persistently poor diabetes control in the Veterans Health Administration: A nationwide cohort study.
    PLoS One. 2019;14:e0214679.
    PubMed     Text format     Abstract available

  46. ALSOUS M, Abdel Jalil M, Odeh M, Al Kurdi R, et al
    Public knowledge, attitudes and practices toward diabetes mellitus: A cross-sectional study from Jordan.
    PLoS One. 2019;14:e0214479.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  47. LIU C, Ge HM, Liu BH, Dong R, et al
    Targeting pericyte-endothelial cell crosstalk by circular RNA-cPWWP2A inhibition aggravates diabetes-induced microvascular dysfunction.
    Proc Natl Acad Sci U S A. 2019 Mar 26. pii: 1814874116.
    PubMed     Text format     Abstract available

  48. GAO P, Uzun Y, He B, Salamati SE, et al
    Risk variants disrupting enhancers of TH1 and TREG cells in type 1 diabetes.
    Proc Natl Acad Sci U S A. 2019 Mar 25. pii: 1815336116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: